Embracing Opportunities to Overcome Challenges When Managing Pain in Older Adults
Release Date: January-30-12
Credit Expiration Date: January-29-13
Senior care pharmacists and others interested in the management of pain in older adults.
Pharmacists: 0.75 Contact Hour (0.075 CEU)
Most older adults experience pain that can interfere with normal functioning. This chronic pain increases the risk of depression, sleep problems, and hospitalization--and contributes negatively to patient quality of life and quality of care. The fact is, older adults who suffer from chronic and breakthrough pain often do not receive adequate pain control.
This activity addresses the numerous barriers that interfere with the ability of clinicians to provide adequate pain management for patients, including regulatory and reimbursement issues, patient comorbidities, concern about side effects, poor medication adherence, and the cognitive issues and dementia many of these patients experience. By improving their knowledge, confidence, and skills, senior care pharmacists have the opportunity to help the entire care team improve pain management in the older patient population.
Kerry W. Cranmer, MD, CMD, FAAHPM
CEO, Geriatric Medical Services
Progressive Care Center & Palliative Care Team
Oklahoma City, OK
Janice M. Scheufler, PharmD, FASCP
Hospice of the Western Reserve
It is the policy of the ASCP to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Dr. Cranmer discloses that he is on the speakers bureau for Lilly, Eiasi, Pfizer, and Purdue.
Dr. Scheufler has no relevant financial conflicts to disclose.
Dr. Joseph Kim has no relevant financial conflicts to disclose.
Ms. Anne Jacobsen has no relevant financial conflicts to disclose.
This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This knowledge-based activity, ACPE Universal Activity #0203-9999-12-020-H01-P,has been assigned 0.75 Contact Hour (0.075 CEU).
Participants must view the activity in its entirety, successfully complete the post-test, and submit an evaluation to receive continuing pharmacy education credit. Credit will be awarded for a score of 75% or better, and a statement may be printed immediately after passing the post-test.
There is no fee to participate in this educational activity.
This activity is supported by an educational grant from Purdue Pharma LP.
© 2012, Medical Communications Media, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, and ASCP. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.